SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Type 2 Diabetes Drug, DPP-4 Inhibitor Linagliptin, is Clinically Effective for Long-Term Use, Cardiff University''s Thirty-Two Country Trial Suggests